Freestone Capital Holdings, LLC Biomarin Pharmaceutical Inc Transaction History

Freestone Capital Holdings, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$71.48 - $86.85 $499,430 - $606,820	-6,987 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$74.28 - $92.69 $135,338 - $168,881	-1,822 Reduced 20.68%	6,987 $539,000
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $25,317 - $32,288	353 Added 4.17%	8,809 $778,000
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $58,918 - $67,350	-788 Reduced 8.52%	8,456 $654,000
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $22,728 - $25,521	-301 Reduced 3.15%	9,244 $771,000
Q1 2021 May 17, 2021	BUY	$74.73 - $90.69 $36,617 - $44,438	490 Added 5.41%	9,545 $721,000
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $31,730 - $39,417	-437 Reduced 4.6%	9,055 $794 Million
Q3 2020 Nov 06, 2020	SELL	$71.87 - $131.03 $27,166 - $49,529	-378 Reduced 3.83%	9,492 $722,000
Q2 2020 Aug 04, 2020	BUY	$79.55 - $124.22 $71,197 - $111,176	895 Added 9.97%	9,870 $1.22 Million
Q1 2020 May 12, 2020	BUY	$71.37 - $96.85 $106,341 - $144,306	1,490 Added 19.91%	8,975 $758,000
Q4 2019 Feb 04, 2020	SELL	$64.27 - $86.37 $85,543 - $114,958	-1,331 Reduced 15.1%	7,485 $633,000
Q3 2019 Nov 07, 2019	BUY	$67.4 - $85.11 $35,317 - $44,597	524 Added 6.32%	8,816 $594,000
Q2 2019 Aug 05, 2019	BUY	$80.35 - $93.9 $66,610 - $77,843	829 Added 11.11%	8,292 $710,000
Q1 2019 May 08, 2019	BUY	$84.2 - $98.62 $308,593 - $361,442	3,665 Added 96.5%	7,463 $663,000
Q4 2018 Feb 12, 2019	BUY	$80.14 - $106.07 $304,371 - $402,853	3,798 New	3,798 $323,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Freestone Capital Holdings, LLC with notifications on news.